Waldenström's macroglobulinemia laboratory findings: Difference between revisions
Sara Mohsin (talk | contribs) |
Sara Mohsin (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Waldenström's macroglobulinemia}} | {{Waldenström's macroglobulinemia}} | ||
{{CMG}} {{AE}}{{RAK}} {{MGS}} | {{CMG}} {{AE}}{{S.M.}}{{RAK}} {{MGS}} | ||
==Overview== | ==Overview== |
Revision as of 20:47, 7 February 2019
Waldenström's macroglobulinemia Microchapters |
Differentiating Waldenström's macroglobulinemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Waldenström's macroglobulinemia laboratory findings On the Web |
American Roentgen Ray Society Images of Waldenström's macroglobulinemia laboratory findings |
Waldenström's macroglobulinemia laboratory findings in the news |
Blogs on Waldenström's macroglobulinemia laboratory findings |
Directions to Hospitals Treating Waldenström's macroglobulinemia |
Risk calculators and risk factors for Waldenström's macroglobulinemia laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]Roukoz A. Karam, M.D.[3] Mirdula Sharma, MBBS [4]
Overview
Laboratory findings consistent with the diagnosis of Waldenström's macroglobulinemia include any cytopenia, elevated LDH, and elevated Beta-2 microglobulin.
Laboratory Findings
WM is mostly suspected when a patient has low blood counts and/or high levels of unusual protein levels on blood tests. Then usually after that, a blood test called serum protein electrophoresis is ordered to find out what type of protein is there. And mostly, only after these tests are done that a biopsy of either the bone marrow or a lymph node is considered to confirm the WM diagnosis. Laboratory findings consistent with the diagnosis of Waldenström macroglobulinemia include:[1]
- Complete blood count:
- Anemia.
- Seen in 40% of newly diagnosed patients and in 80% of symptomatic patients with Waldenström's macroglobulinemia.
- Multi-factorial causes including: decreased RBC synthesis due to bone marrow infiltration, iron deficiency due to gastrointestinal bleeding, and chronic inflammation.
- Thrombocytopenia.
- Due to bone marrow infiltration.
- Due to bone marrow infiltration.
- Neutropenia.
- Due to bone marrow infiltration.
- Lymphocytosis.
- Monocytosis.
- Anemia.
- Peripheral smear:
- Plasmacytoid lymphocytes.
- Normocytic normochromic red blood cells.
- Rouleaux formation.
- Chemistry Lab tests:[2]
- Elevated lactate dehydrogenase (LDH).
- Level indicates the extent of the disease.
- Elevated urea and creatinine.
- Rarely
- Electrolyte abnormalities:
- Elevated erythrocyte sedimentation rate (ESR) and uric acid.
- Rheumatoid factor, cryoglobulins, direct anti-globulin test, and cold agglutinin titre results can be positive.
- Elevated beta-2-microglobulin in proportion to tumor mass.
- Needed to evaluate prognosis.
- Elevated lactate dehydrogenase (LDH).
- Platelet function test and blood coagulation studies:
- Prolonged bleeding time.[3]
- Possibly due to interaction between platelet membrane glycoproteins and IgM paraprotein.
- Abnormalities in prothrombin time, activated partial thromboplastin time, thrombin time, and fibrinogen.
- Prolonged bleeding time.[3]
- Mutational analysis: The MYD88 gene mutation has been found in more than 90% of patients with Waldenstrom's macroglobulinemia.[4]
- Cryocrit:
- This test measures the blood levels of cryoglobulins (proteins that clump together in cool temperatures and can block blood vessels).
- Cold agglutinins:
- Cold agglutinins are antibodies that attack and kill red blood cells, especially at cooler temperatures. These dead cells can then build up and block blood vessels. A blood test can be used to detect these antibodies.
- Beta-2 microglobulin (β2M):
- This test measures another protein made by the cancer cells in WM. This protein itself doesn’t cause any problems, but it’s a useful indicator of a patient’s prognosis (outlook). High levels of β2M are linked with a worse outlook.
- Urinanalysis:
- Proteinuria.
References
- ↑ García-Sanz R, Montoto S, Torrequebrada A, de Coca AG, Petit J, Sureda A; et al. (2001). "Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases". Br J Haematol. 115 (3): 575–82. PMID 11736938.
- ↑ Katzmann JA, Kyle RA, Benson J, Larson DR, Snyder MR, Lust JA; et al. (2009). "Screening panels for detection of monoclonal gammopathies". Clin Chem. 55 (8): 1517–22. doi:10.1373/clinchem.2009.126664. PMC 3773468. PMID 19520758.
- ↑ Penny R, Castaldi PA, Whitsed HM (1971). "Inflammation and haemostasis in paraproteinaemias". Br J Haematol. 20 (1): 35–44. PMID 4924493.
- ↑ Xu L, Hunter ZR, Yang G, Zhou Y, Cao Y, Liu X; et al. (2013). "MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction". Blood. 121 (11): 2051–8. doi:10.1182/blood-2012-09-454355. PMC 3596964. PMID 23321251.